Research summary
5-Amino-1MQ research
A small molecule inhibitor of NNMT (nicotinamide N-methyltransferase) studied for metabolic regulation and adipose tissue browning effects.
Evidence at a glance
What the research says about 5-Amino-1MQ
The 5-Amino-1MQ evidence base cited here is 8 sources — 8 preclinical. Critically, that evidence is almost entirely preclinical (animal and in-vitro) — no human clinical trials are cited, so efficacy and safety in people remain unproven. Regulatory status: Not FDA-approved.
Summary
Key takeaways
- 5-Amino-1MQ is a small molecule (not a peptide) that inhibits the enzyme NNMT (nicotinamide N-methyltransferase), which in turn helps preserve cellular NAD+ and supports mitochondrial and metabolic function.
- It is taken orally; reported animal data put oral bioavailability around 38% with an oral half-life near 7 hours.
- The most-cited findings are improved muscle function and grip strength in aged mice and modest fat loss in obese-mouse models — promising, but a long way from established human benefit.
Overview
5-Amino-1MQ (5-amino-1-methylquinolinium) is a research compound studied for metabolism and longevity. Mechanistically it is an inhibitor of NNMT, an enzyme that consumes the NAD+ precursor pathway; by blunting NNMT it is proposed to raise or preserve cellular NAD+ and, through that, support mitochondrial function, energy metabolism, and possibly fat metabolism.
What Is 5-Amino-1MQ?
It is a small-molecule, orally available inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT methylates nicotinamide (a precursor in the NAD+ salvage pathway); over-activity of NNMT is associated with depleted NAD+ and metabolic dysfunction in fat and muscle tissue. Inhibiting the enzyme is the lever 5-Amino-1MQ is designed to pull.
How It Works
NNMT inhibition → NAD+ preservation
By inhibiting NNMT, 5-Amino-1MQ is proposed to reduce wasteful methylation of nicotinamide and keep more substrate available for NAD+ synthesis, supporting the NAD+-dependent enzymes (sirtuins, PARPs) tied to energy metabolism and cellular repair.
Mitochondrial & metabolic support
Higher NAD+ availability is associated in preclinical work with improved mitochondrial efficiency, reduced oxidative stress, and — in fat tissue — a shift toward energy expenditure, which is the basis for the longevity and body-composition interest. These are mechanistic hypotheses supported by animal data, not demonstrated human outcomes.
Pharmacokinetics (preclinical)
- Oral bioavailability ~38% (rat data)
- Time to peak: roughly 48 minutes
- Half-life: ~7 hours oral (≈3.8 hours IV in rats); largely cleared within ~1.7 days
All pharmacokinetic figures are from animal studies. Human PK has not been characterized.
Research Findings (preclinical)
- Rat pharmacokinetic study (2021): established the ~38% oral bioavailability and oral/IV half-lives.
These are animal results. They motivate human research but do not establish that 5-Amino-1MQ works — or is safe — in people.
Safety
Storage & Quality
- Store cool and dry, away from light and moisture.
- Quality indicators: uniform white-to-off-white capsules/powder, sealed packaging, and a third-party COA showing >98% purity with heavy-metals testing.
- Warning signs: moisture damage, clumping or stickiness, discoloration, or a strong chemical odor (possible contamination or degradation).
Legal & Status
5-Amino-1MQ is not approved by the FDA or any regulatory agency for any indication. It is sold as a research chemical for laboratory use only and is not intended for human consumption.
Citations
8 peer-reviewed sources
All citations link to the original source (PubMed, journal site, or regulatory filing). Independent research database — no vendor influence on what's cited.
Preclinical8 sources
Discovery of Small-Molecule NNMT Inhibitors
NNMT Inhibitors Reverse High-Fat-Diet-Induced Obesity in Mice
NNMT Inhibitor Activates Senescent Muscle Stem Cells
NNMT Inhibition + Reduced-Calorie Diet Normalizes Body Composition in DIO Mice
LC-MS/MS Assay for 5-Amino-1MQ in Rat Plasma
NNMT Inhibitor Anti-Proliferative Activity in HeLa Cells
Reduced Calorie Diet + NNMT Inhibition Effects on DIO Mice Microbiome
NNMT Inhibition Mitigates Obesity-Related Metabolic Dysfunction
Related research
